Vitamin K and direct oral anticoagulants in patients with major bleeding: Risk assessment

被引：1

作者：

Kawada, Tomoyuki ^{[1
]}

机构：

[1] Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2017年 / 235卷

关键词：

Direct oral anticoagulants; Vitamin K anticoagulants; Major bleeding; Intracranial hemorrhage; Mortality; NONVALVULAR ATRIAL-FIBRILLATION;

D O I：

10.1016/j.ijcard.2017.01.029

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：199 / 199

页数：1

共 4 条

[1] Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life [J].

Becattini, Cecilia ;

Franco, Laura ;

Beyer-Westendorf, Jan ;

Masotti, Luca ;

Nitti, Cinzia ;

Vanni, Simone ;

Manina, Giorgia ;

Cattinelli, Sergio ;

Cappelli, Roberto ;

Sbrojavacca, Rodolfo ;

Pomero, Fulvio ;

Marten, Sandra ;

Agnelli, Giancarlo .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 227 :261-266

[2] XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation [J].

Camm, A. John ;

Amarenco, Pierre ;

Haas, Sylvia ;

Hess, Susanne ;

Kirchhof, Paulus ;

Kuhls, Silvia ;

van Eickels, Martin ;

Turpie, Alexander G. G. .

EUROPEAN HEART JOURNAL, 2016, 37 (14) :1145-1153

[3] Real-world evidence of stroke prevention in patients with nonvalvular atrial fibrillation in the United States: the REVISIT-US study [J].

Coleman, Craig I. ;

Antz, Matthias ;

Bowrin, Kevin ;

Evers, Thomas ;

Simard, Edgar P. ;

Bonnemeier, Hendrik ;

Cappato, Riccardo .

CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (12) :2047-2053

[4] Characterizing Major Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Pharmacovigilance Study of 27 467 Patients Taking Rivaroxaban [J].

Tamayo, Sally ;

Peacock, W. Frank ;

Patel, Manesh ;

Sicignano, Nicholas ;

Hopf, Kathleen P. ;

Fields, Larry E. ;

Sarich, Troy ;

Wu, Shujian ;

Yannicelli, Daniel ;

Yuan, Zhong .

CLINICAL CARDIOLOGY, 2015, 38 (02) :63-68

← 1 →